B
Bimagramab
ProductHeard in 1 episode across 1 show since Sep 2026
Bimagrumab is an investigational monoclonal antibody targeting activin type II receptors, studied for increasing muscle mass and improving body composition in conditions including muscle wasting and obesity.
Episodes
1
across 1 show
First heard
Sep 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 1 |
| Oct 2026 | 0 |
Episodes
1 episode featuring Bimagramab, newest first